Clinical radioimmunotherapy of solid-tumors with chemically modified I-131 labeled chimeric TNT monoclonal antibodies.

被引：0
|
作者：
Jiang, C
Zhoang, G
Cesarman, G
Hu, P
Khawli, LA
Epstein, AL
机构：
[1] Shanghai Med Univ, Shanghai 200032, Peoples R China
[2] Natl Inst Nutr, Mexico City, DF, Mexico
[3] Univ So Calif, Los Angeles, CA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 1998年 / 39卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1087
引用
收藏
页码：247P / 247P
页数：1
相关论文
共 50 条
  • [21] Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using 125I-labeled anti-endoglin monoclonal antibodies
    Tabata, M
    Kondo, M
    Haruta, Y
    Seon, BK
    INTERNATIONAL JOURNAL OF CANCER, 1999, 82 (05) : 737 - 742
  • [22] Radioimmunotherapy with intravenously administered 131I-labeled chimeric monoclonal antibody MOv18 in patients with ovarian cancer
    van Zanten-Przybysz, I
    Molthoff, CF
    Roos, JC
    Plaizier, MA
    Visser, GW
    Pijpers, R
    Kenemans, P
    Verheijen, RH
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (07) : 1168 - 1176
  • [23] Radioimmunotargeting with I-131 labeled chimeric G250 monoclonal antibody in patients with renal cell carcinoma.
    Steffens, MG
    Boerman, OC
    Oosterwijk, E
    Oosterhof, GON
    Witjes, JA
    OosterwijkWakka, JC
    Koenders, E
    Debruyne, FMJ
    Corstens, FHM
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 740 - 740
  • [24] RADIOIMMUNOTHERAPY OF XENOGRAFTS OF HUMAN PANCREATIC CARCINOMAS - INTRAVENOUS AND INTRATUMORAL APPLICATION OF I-131-LABELED MONOCLONAL-ANTIBODIES
    KLAPDOR, R
    LANDER, S
    BAHLO, M
    MONTZ, R
    NUCLEAR MEDICINE-NUKLEARMEDIZIN, 1986, 25 (06): : 235 - 238
  • [25] I-131 COUPLED TO MONOCLONAL-ANTIBODIES AS THERAPEUTIC AGENTS FOR NEUROECTODERMALLY DERIVED TUMORS - FACT OR FICTION
    KEMSHEAD, JT
    JONES, DH
    LASHFORD, L
    PRICHARD, J
    GORDON, I
    BREATNACH, F
    COAKHAM, HB
    CANCER DRUG DELIVERY, 1986, 3 (01): : 25 - 43
  • [26] Intralesional radioimmunotherapy of glioblastoma.: Comparison of the results obtained with 131I and 90Y labelled antitenascin monoclonal antibodies.
    Riva, P
    Franceschi, G
    Frattarelli, M
    Riva, N
    Casi, M
    Guiducci, G
    Giuliani, G
    Santimaria, M
    Moscatelli, G
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 272P - 272P
  • [27] THE DETECTION OF VIRALLY INDUCED-TUMORS BY I-131-LABELED AND I-125-LABELED SYNGENEIC MONOCLONAL-ANTIBODIES
    BERENDS, D
    VANGAALEN, JLM
    RHIJNSBURGER, EH
    DEBOTH, NJ
    BREEMAN, W
    BAKKER, WH
    KOOY, P
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1988, 26 (03) : 243 - 249
  • [28] IMMUNOSCINTIGRAPHY AND DISTRIBUTION STUDY OF EXPERIMENTAL-TUMORS USING I-131 LABELED ANTI-FIBRINOGEN ANTIBODIES
    SVIHOVCOVA, P
    KOPRIVOVA, H
    GLAGOLICOVA, A
    NOVAK, F
    SUROVA, H
    DIENSTBIER, Z
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1984, 9 (10): : 478 - 481
  • [29] RADIOIMMUNOSCINTIGRAPHY OF GYNECOLOGIC TUMORS WITH I-131-LABELED ANTI-PLAP MONOCLONAL-ANTIBODIES
    RIKLUND, KE
    EDBOM, G
    MAKIYA, R
    JOHANSSON, B
    GERDES, U
    HIETALA, SO
    EKELUND, L
    STIGBRAND, T
    STENDAHL, U
    ACTA RADIOLOGICA, 1991, 32 (05) : 375 - 380
  • [30] TARGETING AND INITIAL RADIOIMMUNOTHERAPY OF MEDULLARY-THYROID CARCINOMA WITH I-131-LABELED MONOCLONAL-ANTIBODIES TO CARCINOEMBRYONIC ANTIGEN
    JUWEID, M
    SHARKEY, RM
    BEHR, T
    SWAYNE, LC
    RUBIN, AD
    HANLEY, D
    HERSKOVIC, T
    MARKOWITZ, A
    SIEGEL, J
    GOLDENBERG, DM
    CANCER RESEARCH, 1995, 55 (23) : S5946 - S5951
12345